Open AccessThe Prevention of Dementia With Antihypertensive Treatment<subtitle>New Evidence From the Systolic Hypertension in Europe (Syst-Eur) Study</subtitle>
Author(s) -
Françoise Forette
Publication year - 2002
Publication title -
archives of internal medicine
Language(s) - English
Resource type - Journals
eISSN - 1538-3679
pISSN - 0003-9926
DOI - 10.1001/archinte.162.18.2046
Subject(s) - hydrochlorothiazide , medicine , blood pressure , nitrendipine , enalapril , dementia , randomization , placebo , randomized controlled trial , cardiology , angiotensin converting enzyme , disease , alternative medicine , pathology
After the double-blind, placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial ended in February 1997, randomized patients were offered active study medication for a further period of observation.